Assessment of CBC Changes in Breast Cancer Patients Following Treatment with 5-Flourouracil, Adriamycin and Cyclophosphamide (FAC-Protocol) and Adriamycin and Cyclophosphamide (AC-Protocol)
Journal Title: Open Access Journal of Pharmaceutical Research - Year 2017, Vol 1, Issue 6
Abstract
Objective: FAC (5 fluorouracil, Adriamycin and cyclophosphamide) and AC (Adriamycin and cyclophosphamide) protocols have significant anti-tumor activity in patients with breast cancer. Our objective was to evaluate the CBC changes in patients undergoing FAC and AC protocols. Methodology: A comparative retrospective study was performed to determine CBC changes in breast cancer patients following 5-Flourouracil, Adriamycin and Cyclophosphamide (FAC-Protocol) and Adriamycin and cyclophosphamide (ACProtocol) among 150 breast cancer patients following 4 cycles of respective protocols. Marital status, surgical history, stages, diagnosis and receptor status were also determined. The parameters under observation were hemoglobin, platelets, MCV, MCHC, RBC’s, WBC’s, monocytes, lymphocytes, eosinophils and neutrophils. Data was analyzed using SPSS. Results: FAC and AC protocol influenced the values of CBC in breast cancer patients in different patterns. A mild decrease in the Hemoglobin level and a significant decrease in the value of RBC’s and significant increase in the level of MCV was observed in the study population after 4 cycles of both FAC and AC protocols of chemotherapy where most of the parameters such as platelets, MCV, Monocytes, Neutrophils, Eosinophils, Lymphocytes and WBCs remained in the normal range except hemoglobin, MCHC and RBCs by the end of 4th cycle of the therapy. Conclusion: No significant difference was observed with the CBC changes in both protocols. A frequent investigation of CBC parameters and careful selection of chemotherapy protocol should be done in patients who are prone to CBC disturbances.
Authors and Affiliations
Asif U, Yousaf M, Saleem Z*, Raza SA, Iftikhar N, Ibrahim K, Nasir Z, Saeed A and Bashir A
Keywords
Related Articles
- EP ID EP745870
- DOI 10.23880/oajpr-16000131
- Views 39
- Downloads 0
An Extensive Analysis of Natural Bioenhancers: A Review
The concept of bioavailability enhancer is new to the modern system of medicine. Basically, this concept originated in Ayurveda and being used in this system of medicine since centuries. Chemical substances known as "bi...
Density Functional Study of Aflatoxin B1, B2, G1 and G2: NBO and AIM Analyses
Aflatoxin, belonging to the bisfuranocoumarine group of organic compounds, encompasses several species such as aflatoxin B1, B2, G1, and G2. In this study, geometry optimizations of these aflatoxins were conducted using...
Cloud Computing and Biological Data
The diversity of data leads to volume, velocity, variety, variability and value, the “V”s of big data worldwide known. And these are the challenges for biomedical and data scientists to bring proper information out of th...
Quantum Dots: Need to Explore Potential for Delivery of Drugs and Biomolecules
Quantum dots (QDs) are the semiconductor nanoparticles having the range of 2 nm to 10 nm [1]. One of the properties of semiconductor metals of the group IV to group VI of periodic table, to show fluorescence is establish...
Biofield Energy Treatment Based Test Formulation as a Novel and Efficient Approach on Various Biomarkers in human Bones, Heart, Liver, Lungs, and Brain Cells
Multiple organ dysfunction syndromes (MODS) are one of the common reasons for increased mortality rate against healthcare services. The present experiment aimed to determine the impact of the Biofield Energy Treated test...